27 agosto 2021

UK Approves Ronapreve antibody Combo For COVID-19

 

* Ronapreve, Known as REGEN-COV in The United States, Is a Combination of Two Monoclonal Antibodies That Bind to SARS-CoV-2, The Virus That Causes COVID19 .

  • This Binding Prevents The Virus From Infection Cells in the Lining of The Respiratory Tract .

  • The Drug Regulator in the United Kingdom has Approved Ronapreve, Which Regeneron and Roche developed, fory Both Prevention and Treatment .

  • Research Suggests that Administering the Antibodie Combo Soon After Symptoms Develop can Reduce the Chances of Hospitalization and Death .